The specific cellular immunity was stronger in the patients with acute hepatitis B than in those with chronic hepatitis B and liver cirrhosis.
急性乙肝患者特异性细胞免疫功能明显强于慢性乙肝患者及肝炎肝硬化患者。
Methods Disability adjusted life year (DALY) was used to measure BOD of patients with chronic hepatitis B, cirrhosis and liver cancer caused by hepatitis B virus.
方法采用失能调整寿命年指标测量慢性乙肝、肝硬化和肝癌病人的疾病负担。
ObjectiveTo investigate the dynamic change and expression of Matrix Metalloproteinase-9(MMP-9) in patients with chronic hepatitis B(CHB) and liver cirrhosis(LC).
目的研究基质金属蛋白酶9（MMP 9）在慢性肝病患者肝纤维化过程中的表达和动态变化。
Hepatitis B virus (HBV) is a major cause of acute and chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma in humans.
乙型肝炎病毒(HBV)是人类急慢性肝炎、肝硬化和肝细胞癌的主要病因。
HBV can usually escape early and late immune response leading to chronic liver disease-chronic hepatitis B, liver cirrhosis, liver failure and hepatic cellular carcinoma.
HBV通常可以逃避早期和晚期免疫应答导致慢性肝脏疾病——慢性乙型肝炎、乙肝后肝硬化、肝衰竭、肝癌。
The fundamental way of liver cirrhosis prevention and control is to prevent chronic hepatitis B.
预防慢性乙肝是防治肝硬化的根本措施。
The fundamental way of liver cirrhosis prevention and control is to prevent chronic hepatitis B.
预防慢性乙肝是防治肝硬化的根本措施。
应用推荐